1. Introduction {#j_med-2018-0040_s_001}
===============

Food intake and energy homeostasis regulation is a complex process. Humoral and neuronal inputs from peripheral organs (i.e. gastrointestinal tract, adipose tissue) are integrated in well-defined brain regions. Hypothalamus and brainstem centres work up these information and decide on the enhancement or reduction of food intake. However, reflecting the complexity of regulation, higher order neocortical, subcortical and limbic areas are also involved ([Figure 1](#j_med-2018-0040_fig_001){ref-type="fig"}.) \[[@j_med-2018-0040_ref_001]\]. To understand the precise mechanism of food intake regulation researchers established several animal models. Although, majority of these studies were carried out in mice, comprehensive analysis on avians are inevitable for phylogenetical and economic reasons.

![Brain regions involved in food intake regulation (Human hemisphere, midsagittal view).](med-13-264-g001){#j_med-2018-0040_fig_001}

2. The melanin-concentrating hormone (MCH) system in human and rodents {#j_med-2018-0040_s_002}
======================================================================

Pre-melanin-concentrating hormone (PMCH) gene encodes a preprotein. Proteolytical process generates different proteins (i.e. MCH, neuropeptide-glutamic acid-isoleucine, or neuropeptide-glycine-glutamic acid). In mammals MCH is a 19 amino acid peptide, the N-terminus is extended by two additional amino acids, with a highly conserved loop structure. In the central nervous system (CNS), in rodents and human the PMCH mRNA sequences have a high degree of homology with 90% overall nucleotide identity ([Figure 2](#j_med-2018-0040_fig_002){ref-type="fig"}).

![Phylogenetic tree based on the amino acids sequence of melanin-concentrating hormone (MCH). \[Length of lines shows the degree of difference in 6 species compared to the sequence of mouse MCH\].](med-13-264-g002){#j_med-2018-0040_fig_002}

MCH is limited to the magnocellular neurons in the lateral hypothalamus and the zona incerta ([Figure 3](#j_med-2018-0040_fig_003){ref-type="fig"}.). These neurons have monosynaptic connections throughout the brain, projecting to the cortex, amygdala, nucleus accumbens, olfactory tubercle and brainstem nuclei \[[@j_med-2018-0040_ref_002], [@j_med-2018-0040_ref_003]\]. Overexpression of MCH may enhance food intake, contributes to reduced glucose tolerance and provokes insulin resistance. In the last decade several research groups investigated the potential effects of MCH receptor (MCHR) antagonists on food intake regulation \[[@j_med-2018-0040_ref_004]\]. According to the results MCHR antagonists may be beneficial against obesity, anxiety and depression \[[@j_med-2018-0040_ref_003], [@j_med-2018-0040_ref_005]\]. A novel promising MCHR1 antagonist SNAP-7941 caused less food intake and body weight \[[@j_med-2018-0040_ref_006]\].

![Melanin-concentrating hormone immunopositive (brown) cells on formalin fixed paraffin embedded rat brain slides, haematoxylin counterstain. At low magnification (Panel A -- 40x) there are strong immunoreactions in the hypothalamic area (circle). At higher magnification (Panel B -- 400x) the reaction is limited to the cytoplasm (arrow).](med-13-264-g003){#j_med-2018-0040_fig_003}

MCH has two G-coupled receptors, MCHR1 and MCHR2. MCHR1 is 353 amino acids long, has seven transmembrane domains, an aspartic acid--arginine--tyrosine (DRY) motif at the end of the third intracellular loop and three potential glycosylation sites at the N-terminus ([Figure 4](#j_med-2018-0040_fig_004){ref-type="fig"}.). MCHR1 gene is localized on chromosome 22q13.3. The receptor is highly conserved among mammals, sequence homology between human and mouse is 95%; while between human and rat is 96%. When MCH binds to the receptor it suppresses the forskolin-stimulated cAMP activation and increases intracellular Ca^2+^ level \[[@j_med-2018-0040_ref_002], [@j_med-2018-0040_ref_007]\].

![Structure of melanin-concentrating hormone receptor 1 (MCHR1).](med-13-264-g004){#j_med-2018-0040_fig_004}

MCHR1 can couple to G~i~, G~0~ and G~q~ proteins, however the interaction is stronger with G~i~ and G~q~. It stimulates protein kinase C (PKC), phospholipase C (PLC) and other extracellular-signal-regulated kinase pathways ([Figure 5](#j_med-2018-0040_fig_005){ref-type="fig"}.). In the CNS it has diverse effects. G~i~-coupled receptors are known to inhibit voltage-gated Ca^2+^ channels (VGCCs) and to activate K^+^-inward rectifying channels. MCH inhibit Ca^2+^ currents through the N-, P-, and with lesser degree the L-types of VGCCs in the neurons of lateral hypothalamus \[[@j_med-2018-0040_ref_002]\].

![Signalling pathways of melanin-concentrating hormone receptor 1 (MCHR1) (left panel) and MCHR2 (right panel). MCH binding to receptors leading to G protein coupling (Gs, Gi, Gq). While, Gi activation causing decreased amount of cAMP (red arrows), Gq resulting in increased mitogen-activated protein kinase (MAPK) activity (blue arrows) via Ras and elevation of intracellular calcium level (mediated by inositol trisphosphate (IP3) and phospholipase C (PLC) activation). This cascade induces changes in cell proliferation and gene transcription. \[Protein kinase A=PKA; protein kinase C=PKC; diacylglycerol=DAG; MAPK kinase=MEK\] (Adapted from Presse et al. \[[@j_med-2018-0040_ref_024]\])](med-13-264-g005){#j_med-2018-0040_fig_005}

MCHR1 is highly expressed in the cerebral cortex, basal ganglia, hypothalamus, and brainstem. Interestingly, the highest expression is observed in extrahypothalamic areas anterior olfactory nucleus, piriform cortex and olfactory tubercle. High level of MCHR1 is found in the shell of the nucleus accumbens, an area involved in reward-related behaviour. Furthermore, MCHR1 is highly expressed in the amygdala and hippocampus suggesting its role in the regulation of emotions (i.e. fear or anxiety) and memory. In addition, it has an influence on general mood and arousal levels \[[@j_med-2018-0040_ref_002], [@j_med-2018-0040_ref_005], [@j_med-2018-0040_ref_007]\].

MCHR2 receptors are 340 amino acids long, located on the long arm of chromosome 6 (6q16.2-6q21). The homology between MCHR1 and MCHR2 is only 38 %. Surprisingly, rats do not have MCHR2 receptor, whereas it is found in guinea pigs, rabbits, in ferrets, dogs, monkeys and humans. MCHR2 activation increases the intracellular Ca^2+^ level and it couples to G~q~-proteins \[[@j_med-2018-0040_ref_002]\].

In the ob/ob mouse model, the PMCH expression increases two-to three-fold with fasting. Leptin treatment blunts the fasting-induced increase of PMCH mRNA in both the wild type and ob/ob mice. The intracerebroventricular administration of 5 μg MCH to rats led to rapid increase of chow consumption. Compared with control group, MCH-treated animals eat two-three-fold more over a six-hour period. Feeding can also be induced by injection of MCH directly into the paraventricular nucleus. Repetitive intramuscular injection of MCH into rats over a one-week period did not lead to obesity, whereas chronic infusion into the lateral ventricle led to both hyperphagia and weight gain \[[@j_med-2018-0040_ref_002], [@j_med-2018-0040_ref_008], [@j_med-2018-0040_ref_009]\]. These studies experimentally confirmed that MCH is essential to fasting response, but unbalanced expression contributes to positive energy balance leading to health problems.

Furthermore, the cytokine receptor interleukin-6 alfa (IL-6Rα) is co-expressed with MCH and orexin in human and mouse hypothalamus in the hypothalamic, perifornical, dorsal and posterior areas, dorsomedial nucleus and in the zona incerta. In addition, MCH and orexin positive neurons contain IL-6Rα, suggesting that immune mechanisms may also be involved in the orchestration of energy balance. \[[@j_med-2018-0040_ref_010]\].

The *ventromedial nucleus of hypothalamus (VMH)* is a satiety centre and a main target of leptin which inhibits feeding, increases energy expenditure and finally causes weight loss \[[@j_med-2018-0040_ref_011]\].

The *lateral hypothalamic area (LHA)* is the feeding centre. It has an important role in mediating hyperphagia which is induced by hypoglycaemia \[[@j_med-2018-0040_ref_012]\].

The *Dorsomedial hypothalamic nucleus (DMH)* has connection to VMH and the LHA and it integrates the information from these nuclei \[[@j_med-2018-0040_ref_013]\].

The ventromedial aspect of the arcuate nucleus, which produces the orexigenic peptides neuropeptide Y (NPY) and agouti-related peptide (AGRP), contains glutamic acid decarboxylase (GAD) and vesicular gamma-aminobutyric acid (GABA) transporter (VGAT). Surprisingly, in the LHA orexin-producing neurons express vesicular glutamate transporter 1 (VGLUT1) or VGLUT2, but not GAD, whereas some MCH cells contain GAD \[[@j_med-2018-0040_ref_014],[@j_med-2018-0040_ref_015],[@j_med-2018-0040_ref_016]\]. The hypothalamus is the primary CNS region to control energy balance, but is also associated with thirst, reproduction, temperature, hormonal balance and biological rhythms. Lesions of lateral hypothalamus produce aphagia, adipsia and weight loss. As a compensatory mechanism MCH expression increases during fasting and encourages food intake \[[@j_med-2018-0040_ref_002], [@j_med-2018-0040_ref_015],[@j_med-2018-0040_ref_016],[@j_med-2018-0040_ref_017],[@j_med-2018-0040_ref_018]\].

Experimentally MCH administration leads to rapid and robust feeding response, while chronic infusions results in mild obesity. MCH expression changes in states of altered energy balance, such as fasting and obesity. Silencing either PMCH or MCHR genes leads to a lean phenotype \[[@j_med-2018-0040_ref_002]\]. As we discussed MCH antagonists inhibit both feeding and diet-induced obesity \[[@j_med-2018-0040_ref_003],[@j_med-2018-0040_ref_004],[@j_med-2018-0040_ref_005]\].

In mammals, the widespread projections of MCH neurons in the lateral and basal hypothalamus suggest the complex role of peptide in the regulation of feeding behaviour, fluid intake, stress response, reproduction, arousal and sensory-motor integration \[[@j_med-2018-0040_ref_019]\].

3. The MCH system in avians {#j_med-2018-0040_s_003}
===========================

In avians, the diencephalon is highly developed and implicated in numerous physiological processes. A phylogenetic novelty is the very accurate thermoregulation centre located in bird's hypothalamus, which is important to maintain the continuously high body temperature of avians. The diencephalon is divided into three parts like in the other vertebrates i.e. the thalamus, hypothalamus and epithalamus. The hypothalamus is a part of the reticular formation. It contains different secretory neurons which have roles in the neuroendocrine regulation \[[@j_med-2018-0040_ref_020]\].

Cardot *et al*. detected MCH immunopositivity in five species' brain: Leghorn cocks, Guinea hens, quails, goslings and ducks \[[@j_med-2018-0040_ref_021]\]. Neuronal perikarya were strongly positive in hypothalamus mainly in the periventricular hypothalamic nucleus in all species except the cocks, where only few perikarya showed immunoreactivity. Fibres and nerve terminals were very thin and sparse, especially in ducks and quails. In LHA immunopositivity were found in the periventricular nucleus, the ventricular nucleus and the dorsomedial nucleus. A lot of fibers had positive immunoreaction in the medial area of the thalamus. Although most of them were thin, some were long and unramified.

Regarding the brainstem, innervation by MCH positive neurons was observed in all species in the rostral part of the pons and metencephalon, along the fourth ventricle, in the locus coeruleus, the locus subcoeruleus, the oral pontine reticular nucleus and the linear caudal nucleus. In the medulla oblongata some immunopositive fibers were detected in the medial vestibular nucleus, in the raphe nucleus, the posterior area of the caudal pontine reticular nucleus and the vestibular nuclei. In birds the MCH system, especially in the lateral and basal hypothalamus, has an important role in the limbic system and it coordinates the vegetative and endocrine functions as well as the emotional behaviour \[[@j_med-2018-0040_ref_021]\]. The non-mammalian vertebrates studies have identified several mammalian MCHR1/MCHR2-like receptors. According to the predictions seven mammalian MCHR-like receptor exist (MCHR1-MCHR7) in different species such as zebrafish or coelacanths \[[@j_med-2018-0040_ref_022]\]. However, our knowledge on MCHRs in avians is limited due to the absence of experimental studies. In a recent paper Cui *et al*. have identified a MCHR1-like receptor (chicken-MCHR4) and a pseudo MCHR2 in chickens \[[@j_med-2018-0040_ref_023]\]. The cMCHR4 is activated by chicken MCH (cMCH) and induces different signalling pathways. They found that cMCHR4 is not orthologous to human MCHR1. As in human, the discovered receptor is also coupled to G-proteins. Regarding anatomical localisation the cMCH expresses predominantly in the hypothalamus, while cMCHR4 expresses widely in the brain. These findings suggest that MCH is highly conserved within vertebrates. Distribution of cMCHR4 can explain the complex regulatory role of MCH system in birds. In addition, fasting increases cMCH mRNA level in chicken hypothalamus indicating its essential function in controlling avian energy balance \[[@j_med-2018-0040_ref_023]\].

4. Conclusion {#j_med-2018-0040_s_004}
=============

MCH is highly conservative neuropeptide in mammals and avians, which plays a crucial role in the regulation of food intake and affectivity. A development of selective MCH system modulators could become promising therapeutic options in the treatment of obesity and obesity-related diseases (i.e. diabetes) or depression. Furthermore, in agriculture the enhancement of endogenous MCH levels in livestock may contribute to higher and more economical meat yield. However, detailed morphological and physiological analysis of MCH system in different species is essential to examine the potential effects of novel pharmacological agents on energy homeostasis.
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